WY-14643 Reduces Inflammation in Periodontitis
Author Information
Author(s): Briguglio Enrico, Di Paola Rosanna, Paterniti Irene, Mazzon Emanuela, Oteri Giacomo, Cordasco Giancarlo, Cuzzocrea Salvatore
Primary Institution: Universita degli Studi di Messina
Hypothesis
Can the PPAR-α agonist WY14643 reduce inflammation in a rat model of periodontitis?
Conclusion
The study found that WY14643 significantly decreased inflammation and tissue damage in rats with periodontitis.
Supporting Evidence
- WY14643 treatment reduced myeloperoxidase activity, indicating less inflammation.
- Cytokines TNF-α and IL-1β levels were significantly lower in treated rats.
- Histological analysis showed reduced tissue damage in the gingivomucosal tissues of treated rats.
- Treatment with WY14643 prevented IκB-α degradation, indicating reduced NF-κB activation.
- Positive staining for iNOS was abolished in gingivomucosal tissues from treated rats.
- Radiographic analysis showed less bone resorption in the treated group.
Takeaway
This study shows that a drug called WY14643 can help reduce swelling and damage in the gums of rats with gum disease.
Methodology
Male Sprague-Dawley rats were treated with WY14643 for eight days after inducing periodontitis with ligature, and various inflammatory markers were assessed.
Limitations
The study was conducted in a rat model, which may not fully replicate human periodontitis.
Participant Demographics
Male Sprague-Dawley rats, weighing 280-400g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website